Global 3D Printing Pharmaceuticals Supply, Demand and Key Producers, 2023-2029
The global 3D Printing Pharmaceuticals market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
This report studies the global 3D Printing Pharmaceuticals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for 3D Printing Pharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 3D Printing Pharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global 3D Printing Pharmaceuticals total production and demand, 2018-2029, (K Units)
Global 3D Printing Pharmaceuticals total production value, 2018-2029, (USD Million)
Global 3D Printing Pharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 3D Printing Pharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global 3D Printing Pharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global 3D Printing Pharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 3D Printing Pharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global 3D Printing Pharmaceuticals Market, By Region:
1. How big is the global 3D Printing Pharmaceuticals market?
2. What is the demand of the global 3D Printing Pharmaceuticals market?
3. What is the year over year growth of the global 3D Printing Pharmaceuticals market?
4. What is the production and production value of the global 3D Printing Pharmaceuticals market?
5. Who are the key producers in the global 3D Printing Pharmaceuticals market?
6. What are the growth factors driving the market demand?
3D printing pharmaceuticals can be applied to the field of solid preparations, which are dominated by small molecule drugs. Compared with traditional solid preparations, 3D printing pharmaceuticals can better control drug release, improve drug efficacy, reduce drug side effects, and reduce dosing frequency.
This report studies the global 3D Printing Pharmaceuticals production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for 3D Printing Pharmaceuticals, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of 3D Printing Pharmaceuticals that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global 3D Printing Pharmaceuticals total production and demand, 2018-2029, (K Units)
Global 3D Printing Pharmaceuticals total production value, 2018-2029, (USD Million)
Global 3D Printing Pharmaceuticals production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: 3D Printing Pharmaceuticals domestic production, consumption, key domestic manufacturers and share
Global 3D Printing Pharmaceuticals production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global 3D Printing Pharmaceuticals production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global 3D Printing Pharmaceuticals market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Triastek,Inc., Aprecia, AstraZeneca, FabRx, Multiply Labs, DiHeSys, Merck, Merck KGaA and TNO, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World 3D Printing Pharmaceuticals market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global 3D Printing Pharmaceuticals Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- FDM
- SLS
- PB
- SLA
- SSE
- DPE
- DOD
- MDD
- MED
- Personalized Pharmacy
- Nutrients
- Triastek,Inc.
- Aprecia
- AstraZeneca
- FabRx
- Multiply Labs
- DiHeSys
- Merck
- Merck KGaA
- TNO
- Therics
1. How big is the global 3D Printing Pharmaceuticals market?
2. What is the demand of the global 3D Printing Pharmaceuticals market?
3. What is the year over year growth of the global 3D Printing Pharmaceuticals market?
4. What is the production and production value of the global 3D Printing Pharmaceuticals market?
5. Who are the key producers in the global 3D Printing Pharmaceuticals market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 3D Printing Pharmaceuticals Introduction
1.2 World 3D Printing Pharmaceuticals Supply & Forecast
1.2.1 World 3D Printing Pharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World 3D Printing Pharmaceuticals Production (2018-2029)
1.2.3 World 3D Printing Pharmaceuticals Pricing Trends (2018-2029)
1.3 World 3D Printing Pharmaceuticals Production by Region (Based on Production Site)
1.3.1 World 3D Printing Pharmaceuticals Production Value by Region (2018-2029)
1.3.2 World 3D Printing Pharmaceuticals Production by Region (2018-2029)
1.3.3 World 3D Printing Pharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America 3D Printing Pharmaceuticals Production (2018-2029)
1.3.5 Europe 3D Printing Pharmaceuticals Production (2018-2029)
1.3.6 China 3D Printing Pharmaceuticals Production (2018-2029)
1.3.7 Japan 3D Printing Pharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 3D Printing Pharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 3D Printing Pharmaceuticals Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World 3D Printing Pharmaceuticals Demand (2018-2029)
2.2 World 3D Printing Pharmaceuticals Consumption by Region
2.2.1 World 3D Printing Pharmaceuticals Consumption by Region (2018-2023)
2.2.2 World 3D Printing Pharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States 3D Printing Pharmaceuticals Consumption (2018-2029)
2.4 China 3D Printing Pharmaceuticals Consumption (2018-2029)
2.5 Europe 3D Printing Pharmaceuticals Consumption (2018-2029)
2.6 Japan 3D Printing Pharmaceuticals Consumption (2018-2029)
2.7 South Korea 3D Printing Pharmaceuticals Consumption (2018-2029)
2.8 ASEAN 3D Printing Pharmaceuticals Consumption (2018-2029)
2.9 India 3D Printing Pharmaceuticals Consumption (2018-2029)
3 WORLD 3D PRINTING PHARMACEUTICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World 3D Printing Pharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World 3D Printing Pharmaceuticals Production by Manufacturer (2018-2023)
3.3 World 3D Printing Pharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 3D Printing Pharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global 3D Printing Pharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for 3D Printing Pharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for 3D Printing Pharmaceuticals in 2022
3.6 3D Printing Pharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 3D Printing Pharmaceuticals Market: Region Footprint
3.6.2 3D Printing Pharmaceuticals Market: Company Product Type Footprint
3.6.3 3D Printing Pharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: 3D Printing Pharmaceuticals Production Value Comparison
4.1.1 United States VS China: 3D Printing Pharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: 3D Printing Pharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: 3D Printing Pharmaceuticals Production Comparison
4.2.1 United States VS China: 3D Printing Pharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 3D Printing Pharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: 3D Printing Pharmaceuticals Consumption Comparison
4.3.1 United States VS China: 3D Printing Pharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: 3D Printing Pharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based 3D Printing Pharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
4.5 China Based 3D Printing Pharmaceuticals Manufacturers and Market Share
4.5.1 China Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
4.6 Rest of World Based 3D Printing Pharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World 3D Printing Pharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 FDM
5.2.2 SLS
5.2.3 PB
5.2.4 SLA
5.2.5 SSE
5.2.6 DPE
5.2.7 DOD
5.2.8 MDD
5.2.9 MED
5.3 Market Segment by Type
5.3.1 World 3D Printing Pharmaceuticals Production by Type (2018-2029)
5.3.2 World 3D Printing Pharmaceuticals Production Value by Type (2018-2029)
5.3.3 World 3D Printing Pharmaceuticals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World 3D Printing Pharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Personalized Pharmacy
6.2.2 Nutrients
6.3 Market Segment by Application
6.3.1 World 3D Printing Pharmaceuticals Production by Application (2018-2029)
6.3.2 World 3D Printing Pharmaceuticals Production Value by Application (2018-2029)
6.3.3 World 3D Printing Pharmaceuticals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Triastek,Inc.
7.1.1 Triastek,Inc. Details
7.1.2 Triastek,Inc. Major Business
7.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Product and Services
7.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Triastek,Inc. Recent Developments/Updates
7.1.6 Triastek,Inc. Competitive Strengths & Weaknesses
7.2 Aprecia
7.2.1 Aprecia Details
7.2.2 Aprecia Major Business
7.2.3 Aprecia 3D Printing Pharmaceuticals Product and Services
7.2.4 Aprecia 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aprecia Recent Developments/Updates
7.2.6 Aprecia Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca 3D Printing Pharmaceuticals Product and Services
7.3.4 AstraZeneca 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 FabRx
7.4.1 FabRx Details
7.4.2 FabRx Major Business
7.4.3 FabRx 3D Printing Pharmaceuticals Product and Services
7.4.4 FabRx 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 FabRx Recent Developments/Updates
7.4.6 FabRx Competitive Strengths & Weaknesses
7.5 Multiply Labs
7.5.1 Multiply Labs Details
7.5.2 Multiply Labs Major Business
7.5.3 Multiply Labs 3D Printing Pharmaceuticals Product and Services
7.5.4 Multiply Labs 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Multiply Labs Recent Developments/Updates
7.5.6 Multiply Labs Competitive Strengths & Weaknesses
7.6 DiHeSys
7.6.1 DiHeSys Details
7.6.2 DiHeSys Major Business
7.6.3 DiHeSys 3D Printing Pharmaceuticals Product and Services
7.6.4 DiHeSys 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 DiHeSys Recent Developments/Updates
7.6.6 DiHeSys Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck 3D Printing Pharmaceuticals Product and Services
7.7.4 Merck 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Merck KGaA
7.8.1 Merck KGaA Details
7.8.2 Merck KGaA Major Business
7.8.3 Merck KGaA 3D Printing Pharmaceuticals Product and Services
7.8.4 Merck KGaA 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck KGaA Recent Developments/Updates
7.8.6 Merck KGaA Competitive Strengths & Weaknesses
7.9 TNO
7.9.1 TNO Details
7.9.2 TNO Major Business
7.9.3 TNO 3D Printing Pharmaceuticals Product and Services
7.9.4 TNO 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 TNO Recent Developments/Updates
7.9.6 TNO Competitive Strengths & Weaknesses
7.10 Therics
7.10.1 Therics Details
7.10.2 Therics Major Business
7.10.3 Therics 3D Printing Pharmaceuticals Product and Services
7.10.4 Therics 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Therics Recent Developments/Updates
7.10.6 Therics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 3D Printing Pharmaceuticals Industry Chain
8.2 3D Printing Pharmaceuticals Upstream Analysis
8.2.1 3D Printing Pharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of 3D Printing Pharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 3D Printing Pharmaceuticals Production Mode
8.6 3D Printing Pharmaceuticals Procurement Model
8.7 3D Printing Pharmaceuticals Industry Sales Model and Sales Channels
8.7.1 3D Printing Pharmaceuticals Sales Model
8.7.2 3D Printing Pharmaceuticals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 3D Printing Pharmaceuticals Introduction
1.2 World 3D Printing Pharmaceuticals Supply & Forecast
1.2.1 World 3D Printing Pharmaceuticals Production Value (2018 & 2022 & 2029)
1.2.2 World 3D Printing Pharmaceuticals Production (2018-2029)
1.2.3 World 3D Printing Pharmaceuticals Pricing Trends (2018-2029)
1.3 World 3D Printing Pharmaceuticals Production by Region (Based on Production Site)
1.3.1 World 3D Printing Pharmaceuticals Production Value by Region (2018-2029)
1.3.2 World 3D Printing Pharmaceuticals Production by Region (2018-2029)
1.3.3 World 3D Printing Pharmaceuticals Average Price by Region (2018-2029)
1.3.4 North America 3D Printing Pharmaceuticals Production (2018-2029)
1.3.5 Europe 3D Printing Pharmaceuticals Production (2018-2029)
1.3.6 China 3D Printing Pharmaceuticals Production (2018-2029)
1.3.7 Japan 3D Printing Pharmaceuticals Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 3D Printing Pharmaceuticals Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 3D Printing Pharmaceuticals Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World 3D Printing Pharmaceuticals Demand (2018-2029)
2.2 World 3D Printing Pharmaceuticals Consumption by Region
2.2.1 World 3D Printing Pharmaceuticals Consumption by Region (2018-2023)
2.2.2 World 3D Printing Pharmaceuticals Consumption Forecast by Region (2024-2029)
2.3 United States 3D Printing Pharmaceuticals Consumption (2018-2029)
2.4 China 3D Printing Pharmaceuticals Consumption (2018-2029)
2.5 Europe 3D Printing Pharmaceuticals Consumption (2018-2029)
2.6 Japan 3D Printing Pharmaceuticals Consumption (2018-2029)
2.7 South Korea 3D Printing Pharmaceuticals Consumption (2018-2029)
2.8 ASEAN 3D Printing Pharmaceuticals Consumption (2018-2029)
2.9 India 3D Printing Pharmaceuticals Consumption (2018-2029)
3 WORLD 3D PRINTING PHARMACEUTICALS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World 3D Printing Pharmaceuticals Production Value by Manufacturer (2018-2023)
3.2 World 3D Printing Pharmaceuticals Production by Manufacturer (2018-2023)
3.3 World 3D Printing Pharmaceuticals Average Price by Manufacturer (2018-2023)
3.4 3D Printing Pharmaceuticals Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global 3D Printing Pharmaceuticals Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for 3D Printing Pharmaceuticals in 2022
3.5.3 Global Concentration Ratios (CR8) for 3D Printing Pharmaceuticals in 2022
3.6 3D Printing Pharmaceuticals Market: Overall Company Footprint Analysis
3.6.1 3D Printing Pharmaceuticals Market: Region Footprint
3.6.2 3D Printing Pharmaceuticals Market: Company Product Type Footprint
3.6.3 3D Printing Pharmaceuticals Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: 3D Printing Pharmaceuticals Production Value Comparison
4.1.1 United States VS China: 3D Printing Pharmaceuticals Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: 3D Printing Pharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: 3D Printing Pharmaceuticals Production Comparison
4.2.1 United States VS China: 3D Printing Pharmaceuticals Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: 3D Printing Pharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: 3D Printing Pharmaceuticals Consumption Comparison
4.3.1 United States VS China: 3D Printing Pharmaceuticals Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: 3D Printing Pharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based 3D Printing Pharmaceuticals Manufacturers and Market Share, 2018-2023
4.4.1 United States Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.4.3 United States Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
4.5 China Based 3D Printing Pharmaceuticals Manufacturers and Market Share
4.5.1 China Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.5.3 China Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
4.6 Rest of World Based 3D Printing Pharmaceuticals Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World 3D Printing Pharmaceuticals Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 FDM
5.2.2 SLS
5.2.3 PB
5.2.4 SLA
5.2.5 SSE
5.2.6 DPE
5.2.7 DOD
5.2.8 MDD
5.2.9 MED
5.3 Market Segment by Type
5.3.1 World 3D Printing Pharmaceuticals Production by Type (2018-2029)
5.3.2 World 3D Printing Pharmaceuticals Production Value by Type (2018-2029)
5.3.3 World 3D Printing Pharmaceuticals Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World 3D Printing Pharmaceuticals Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Personalized Pharmacy
6.2.2 Nutrients
6.3 Market Segment by Application
6.3.1 World 3D Printing Pharmaceuticals Production by Application (2018-2029)
6.3.2 World 3D Printing Pharmaceuticals Production Value by Application (2018-2029)
6.3.3 World 3D Printing Pharmaceuticals Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Triastek,Inc.
7.1.1 Triastek,Inc. Details
7.1.2 Triastek,Inc. Major Business
7.1.3 Triastek,Inc. 3D Printing Pharmaceuticals Product and Services
7.1.4 Triastek,Inc. 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Triastek,Inc. Recent Developments/Updates
7.1.6 Triastek,Inc. Competitive Strengths & Weaknesses
7.2 Aprecia
7.2.1 Aprecia Details
7.2.2 Aprecia Major Business
7.2.3 Aprecia 3D Printing Pharmaceuticals Product and Services
7.2.4 Aprecia 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Aprecia Recent Developments/Updates
7.2.6 Aprecia Competitive Strengths & Weaknesses
7.3 AstraZeneca
7.3.1 AstraZeneca Details
7.3.2 AstraZeneca Major Business
7.3.3 AstraZeneca 3D Printing Pharmaceuticals Product and Services
7.3.4 AstraZeneca 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 AstraZeneca Recent Developments/Updates
7.3.6 AstraZeneca Competitive Strengths & Weaknesses
7.4 FabRx
7.4.1 FabRx Details
7.4.2 FabRx Major Business
7.4.3 FabRx 3D Printing Pharmaceuticals Product and Services
7.4.4 FabRx 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 FabRx Recent Developments/Updates
7.4.6 FabRx Competitive Strengths & Weaknesses
7.5 Multiply Labs
7.5.1 Multiply Labs Details
7.5.2 Multiply Labs Major Business
7.5.3 Multiply Labs 3D Printing Pharmaceuticals Product and Services
7.5.4 Multiply Labs 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Multiply Labs Recent Developments/Updates
7.5.6 Multiply Labs Competitive Strengths & Weaknesses
7.6 DiHeSys
7.6.1 DiHeSys Details
7.6.2 DiHeSys Major Business
7.6.3 DiHeSys 3D Printing Pharmaceuticals Product and Services
7.6.4 DiHeSys 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 DiHeSys Recent Developments/Updates
7.6.6 DiHeSys Competitive Strengths & Weaknesses
7.7 Merck
7.7.1 Merck Details
7.7.2 Merck Major Business
7.7.3 Merck 3D Printing Pharmaceuticals Product and Services
7.7.4 Merck 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Merck Recent Developments/Updates
7.7.6 Merck Competitive Strengths & Weaknesses
7.8 Merck KGaA
7.8.1 Merck KGaA Details
7.8.2 Merck KGaA Major Business
7.8.3 Merck KGaA 3D Printing Pharmaceuticals Product and Services
7.8.4 Merck KGaA 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Merck KGaA Recent Developments/Updates
7.8.6 Merck KGaA Competitive Strengths & Weaknesses
7.9 TNO
7.9.1 TNO Details
7.9.2 TNO Major Business
7.9.3 TNO 3D Printing Pharmaceuticals Product and Services
7.9.4 TNO 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 TNO Recent Developments/Updates
7.9.6 TNO Competitive Strengths & Weaknesses
7.10 Therics
7.10.1 Therics Details
7.10.2 Therics Major Business
7.10.3 Therics 3D Printing Pharmaceuticals Product and Services
7.10.4 Therics 3D Printing Pharmaceuticals Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Therics Recent Developments/Updates
7.10.6 Therics Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 3D Printing Pharmaceuticals Industry Chain
8.2 3D Printing Pharmaceuticals Upstream Analysis
8.2.1 3D Printing Pharmaceuticals Core Raw Materials
8.2.2 Main Manufacturers of 3D Printing Pharmaceuticals Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 3D Printing Pharmaceuticals Production Mode
8.6 3D Printing Pharmaceuticals Procurement Model
8.7 3D Printing Pharmaceuticals Industry Sales Model and Sales Channels
8.7.1 3D Printing Pharmaceuticals Sales Model
8.7.2 3D Printing Pharmaceuticals Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World 3D Printing Pharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World 3D Printing Pharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World 3D Printing Pharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World 3D Printing Pharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World 3D Printing Pharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World 3D Printing Pharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World 3D Printing Pharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World 3D Printing Pharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World 3D Printing Pharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. 3D Printing Pharmaceuticals Major Market Trends
Table 13. World 3D Printing Pharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World 3D Printing Pharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World 3D Printing Pharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World 3D Printing Pharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key 3D Printing Pharmaceuticals Producers in 2022
Table 18. World 3D Printing Pharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key 3D Printing Pharmaceuticals Producers in 2022
Table 20. World 3D Printing Pharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global 3D Printing Pharmaceuticals Company Evaluation Quadrant
Table 22. World 3D Printing Pharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and 3D Printing Pharmaceuticals Production Site of Key Manufacturer
Table 24. 3D Printing Pharmaceuticals Market: Company Product Type Footprint
Table 25. 3D Printing Pharmaceuticals Market: Company Product Application Footprint
Table 26. 3D Printing Pharmaceuticals Competitive Factors
Table 27. 3D Printing Pharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. 3D Printing Pharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China 3D Printing Pharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China 3D Printing Pharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China 3D Printing Pharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 37. China Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 47. World 3D Printing Pharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World 3D Printing Pharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World 3D Printing Pharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World 3D Printing Pharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World 3D Printing Pharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World 3D Printing Pharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World 3D Printing Pharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World 3D Printing Pharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World 3D Printing Pharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World 3D Printing Pharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World 3D Printing Pharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World 3D Printing Pharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World 3D Printing Pharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World 3D Printing Pharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Triastek,Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Triastek,Inc. Major Business
Table 63. Triastek,Inc. 3D Printing Pharmaceuticals Product and Services
Table 64. Triastek,Inc. 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Triastek,Inc. Recent Developments/Updates
Table 66. Triastek,Inc. Competitive Strengths & Weaknesses
Table 67. Aprecia Basic Information, Manufacturing Base and Competitors
Table 68. Aprecia Major Business
Table 69. Aprecia 3D Printing Pharmaceuticals Product and Services
Table 70. Aprecia 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aprecia Recent Developments/Updates
Table 72. Aprecia Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca 3D Printing Pharmaceuticals Product and Services
Table 76. AstraZeneca 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. FabRx Basic Information, Manufacturing Base and Competitors
Table 80. FabRx Major Business
Table 81. FabRx 3D Printing Pharmaceuticals Product and Services
Table 82. FabRx 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. FabRx Recent Developments/Updates
Table 84. FabRx Competitive Strengths & Weaknesses
Table 85. Multiply Labs Basic Information, Manufacturing Base and Competitors
Table 86. Multiply Labs Major Business
Table 87. Multiply Labs 3D Printing Pharmaceuticals Product and Services
Table 88. Multiply Labs 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Multiply Labs Recent Developments/Updates
Table 90. Multiply Labs Competitive Strengths & Weaknesses
Table 91. DiHeSys Basic Information, Manufacturing Base and Competitors
Table 92. DiHeSys Major Business
Table 93. DiHeSys 3D Printing Pharmaceuticals Product and Services
Table 94. DiHeSys 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. DiHeSys Recent Developments/Updates
Table 96. DiHeSys Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck 3D Printing Pharmaceuticals Product and Services
Table 100. Merck 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 104. Merck KGaA Major Business
Table 105. Merck KGaA 3D Printing Pharmaceuticals Product and Services
Table 106. Merck KGaA 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck KGaA Recent Developments/Updates
Table 108. Merck KGaA Competitive Strengths & Weaknesses
Table 109. TNO Basic Information, Manufacturing Base and Competitors
Table 110. TNO Major Business
Table 111. TNO 3D Printing Pharmaceuticals Product and Services
Table 112. TNO 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. TNO Recent Developments/Updates
Table 114. Therics Basic Information, Manufacturing Base and Competitors
Table 115. Therics Major Business
Table 116. Therics 3D Printing Pharmaceuticals Product and Services
Table 117. Therics 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of 3D Printing Pharmaceuticals Upstream (Raw Materials)
Table 119. 3D Printing Pharmaceuticals Typical Customers
Table 120. 3D Printing Pharmaceuticals Typical Distributors
Table 1. World 3D Printing Pharmaceuticals Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World 3D Printing Pharmaceuticals Production Value by Region (2018-2023) & (USD Million)
Table 3. World 3D Printing Pharmaceuticals Production Value by Region (2024-2029) & (USD Million)
Table 4. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2018-2023)
Table 5. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2024-2029)
Table 6. World 3D Printing Pharmaceuticals Production by Region (2018-2023) & (K Units)
Table 7. World 3D Printing Pharmaceuticals Production by Region (2024-2029) & (K Units)
Table 8. World 3D Printing Pharmaceuticals Production Market Share by Region (2018-2023)
Table 9. World 3D Printing Pharmaceuticals Production Market Share by Region (2024-2029)
Table 10. World 3D Printing Pharmaceuticals Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World 3D Printing Pharmaceuticals Average Price by Region (2024-2029) & (US$/Unit)
Table 12. 3D Printing Pharmaceuticals Major Market Trends
Table 13. World 3D Printing Pharmaceuticals Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World 3D Printing Pharmaceuticals Consumption by Region (2018-2023) & (K Units)
Table 15. World 3D Printing Pharmaceuticals Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World 3D Printing Pharmaceuticals Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key 3D Printing Pharmaceuticals Producers in 2022
Table 18. World 3D Printing Pharmaceuticals Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key 3D Printing Pharmaceuticals Producers in 2022
Table 20. World 3D Printing Pharmaceuticals Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global 3D Printing Pharmaceuticals Company Evaluation Quadrant
Table 22. World 3D Printing Pharmaceuticals Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and 3D Printing Pharmaceuticals Production Site of Key Manufacturer
Table 24. 3D Printing Pharmaceuticals Market: Company Product Type Footprint
Table 25. 3D Printing Pharmaceuticals Market: Company Product Application Footprint
Table 26. 3D Printing Pharmaceuticals Competitive Factors
Table 27. 3D Printing Pharmaceuticals New Entrant and Capacity Expansion Plans
Table 28. 3D Printing Pharmaceuticals Mergers & Acquisitions Activity
Table 29. United States VS China 3D Printing Pharmaceuticals Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China 3D Printing Pharmaceuticals Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China 3D Printing Pharmaceuticals Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 37. China Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 42. Rest of World Based 3D Printing Pharmaceuticals Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Market Share (2018-2023)
Table 47. World 3D Printing Pharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World 3D Printing Pharmaceuticals Production by Type (2018-2023) & (K Units)
Table 49. World 3D Printing Pharmaceuticals Production by Type (2024-2029) & (K Units)
Table 50. World 3D Printing Pharmaceuticals Production Value by Type (2018-2023) & (USD Million)
Table 51. World 3D Printing Pharmaceuticals Production Value by Type (2024-2029) & (USD Million)
Table 52. World 3D Printing Pharmaceuticals Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World 3D Printing Pharmaceuticals Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World 3D Printing Pharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World 3D Printing Pharmaceuticals Production by Application (2018-2023) & (K Units)
Table 56. World 3D Printing Pharmaceuticals Production by Application (2024-2029) & (K Units)
Table 57. World 3D Printing Pharmaceuticals Production Value by Application (2018-2023) & (USD Million)
Table 58. World 3D Printing Pharmaceuticals Production Value by Application (2024-2029) & (USD Million)
Table 59. World 3D Printing Pharmaceuticals Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World 3D Printing Pharmaceuticals Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Triastek,Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Triastek,Inc. Major Business
Table 63. Triastek,Inc. 3D Printing Pharmaceuticals Product and Services
Table 64. Triastek,Inc. 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Triastek,Inc. Recent Developments/Updates
Table 66. Triastek,Inc. Competitive Strengths & Weaknesses
Table 67. Aprecia Basic Information, Manufacturing Base and Competitors
Table 68. Aprecia Major Business
Table 69. Aprecia 3D Printing Pharmaceuticals Product and Services
Table 70. Aprecia 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Aprecia Recent Developments/Updates
Table 72. Aprecia Competitive Strengths & Weaknesses
Table 73. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 74. AstraZeneca Major Business
Table 75. AstraZeneca 3D Printing Pharmaceuticals Product and Services
Table 76. AstraZeneca 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. AstraZeneca Recent Developments/Updates
Table 78. AstraZeneca Competitive Strengths & Weaknesses
Table 79. FabRx Basic Information, Manufacturing Base and Competitors
Table 80. FabRx Major Business
Table 81. FabRx 3D Printing Pharmaceuticals Product and Services
Table 82. FabRx 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. FabRx Recent Developments/Updates
Table 84. FabRx Competitive Strengths & Weaknesses
Table 85. Multiply Labs Basic Information, Manufacturing Base and Competitors
Table 86. Multiply Labs Major Business
Table 87. Multiply Labs 3D Printing Pharmaceuticals Product and Services
Table 88. Multiply Labs 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Multiply Labs Recent Developments/Updates
Table 90. Multiply Labs Competitive Strengths & Weaknesses
Table 91. DiHeSys Basic Information, Manufacturing Base and Competitors
Table 92. DiHeSys Major Business
Table 93. DiHeSys 3D Printing Pharmaceuticals Product and Services
Table 94. DiHeSys 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. DiHeSys Recent Developments/Updates
Table 96. DiHeSys Competitive Strengths & Weaknesses
Table 97. Merck Basic Information, Manufacturing Base and Competitors
Table 98. Merck Major Business
Table 99. Merck 3D Printing Pharmaceuticals Product and Services
Table 100. Merck 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Merck Recent Developments/Updates
Table 102. Merck Competitive Strengths & Weaknesses
Table 103. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 104. Merck KGaA Major Business
Table 105. Merck KGaA 3D Printing Pharmaceuticals Product and Services
Table 106. Merck KGaA 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Merck KGaA Recent Developments/Updates
Table 108. Merck KGaA Competitive Strengths & Weaknesses
Table 109. TNO Basic Information, Manufacturing Base and Competitors
Table 110. TNO Major Business
Table 111. TNO 3D Printing Pharmaceuticals Product and Services
Table 112. TNO 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. TNO Recent Developments/Updates
Table 114. Therics Basic Information, Manufacturing Base and Competitors
Table 115. Therics Major Business
Table 116. Therics 3D Printing Pharmaceuticals Product and Services
Table 117. Therics 3D Printing Pharmaceuticals Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 118. Global Key Players of 3D Printing Pharmaceuticals Upstream (Raw Materials)
Table 119. 3D Printing Pharmaceuticals Typical Customers
Table 120. 3D Printing Pharmaceuticals Typical Distributors
LIST OF FIGURES
Figure 1. 3D Printing Pharmaceuticals Picture
Figure 2. World 3D Printing Pharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 3D Printing Pharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World 3D Printing Pharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 6. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World 3D Printing Pharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 12. 3D Printing Pharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World 3D Printing Pharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of 3D Printing Pharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for 3D Printing Pharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for 3D Printing Pharmaceuticals Markets in 2022
Figure 26. United States VS China: 3D Printing Pharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: 3D Printing Pharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 3D Printing Pharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 32. World 3D Printing Pharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World 3D Printing Pharmaceuticals Production Value Market Share by Type in 2022
Figure 34. FDM
Figure 35. SLS
Figure 36. PB
Figure 37. SLA
Figure 38. SSE
Figure 39. DPE
Figure 40. DOD
Figure 41. MDD
Figure 42. MED
Figure 43. World 3D Printing Pharmaceuticals Production Market Share by Type (2018-2029)
Figure 44. World 3D Printing Pharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 45. World 3D Printing Pharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 46. World 3D Printing Pharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 47. World 3D Printing Pharmaceuticals Production Value Market Share by Application in 2022
Figure 48. Personalized Pharmacy
Figure 49. Nutrients
Figure 50. World 3D Printing Pharmaceuticals Production Market Share by Application (2018-2029)
Figure 51. World 3D Printing Pharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 52. World 3D Printing Pharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. 3D Printing Pharmaceuticals Industry Chain
Figure 54. 3D Printing Pharmaceuticals Procurement Model
Figure 55. 3D Printing Pharmaceuticals Sales Model
Figure 56. 3D Printing Pharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
Figure 1. 3D Printing Pharmaceuticals Picture
Figure 2. World 3D Printing Pharmaceuticals Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World 3D Printing Pharmaceuticals Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 5. World 3D Printing Pharmaceuticals Average Price (2018-2029) & (US$/Unit)
Figure 6. World 3D Printing Pharmaceuticals Production Value Market Share by Region (2018-2029)
Figure 7. World 3D Printing Pharmaceuticals Production Market Share by Region (2018-2029)
Figure 8. North America 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 9. Europe 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 10. China 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 11. Japan 3D Printing Pharmaceuticals Production (2018-2029) & (K Units)
Figure 12. 3D Printing Pharmaceuticals Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 15. World 3D Printing Pharmaceuticals Consumption Market Share by Region (2018-2029)
Figure 16. United States 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 17. China 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 18. Europe 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 19. Japan 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 20. South Korea 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 21. ASEAN 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 22. India 3D Printing Pharmaceuticals Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of 3D Printing Pharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for 3D Printing Pharmaceuticals Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for 3D Printing Pharmaceuticals Markets in 2022
Figure 26. United States VS China: 3D Printing Pharmaceuticals Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: 3D Printing Pharmaceuticals Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: 3D Printing Pharmaceuticals Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 30. China Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 31. Rest of World Based Manufacturers 3D Printing Pharmaceuticals Production Market Share 2022
Figure 32. World 3D Printing Pharmaceuticals Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World 3D Printing Pharmaceuticals Production Value Market Share by Type in 2022
Figure 34. FDM
Figure 35. SLS
Figure 36. PB
Figure 37. SLA
Figure 38. SSE
Figure 39. DPE
Figure 40. DOD
Figure 41. MDD
Figure 42. MED
Figure 43. World 3D Printing Pharmaceuticals Production Market Share by Type (2018-2029)
Figure 44. World 3D Printing Pharmaceuticals Production Value Market Share by Type (2018-2029)
Figure 45. World 3D Printing Pharmaceuticals Average Price by Type (2018-2029) & (US$/Unit)
Figure 46. World 3D Printing Pharmaceuticals Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 47. World 3D Printing Pharmaceuticals Production Value Market Share by Application in 2022
Figure 48. Personalized Pharmacy
Figure 49. Nutrients
Figure 50. World 3D Printing Pharmaceuticals Production Market Share by Application (2018-2029)
Figure 51. World 3D Printing Pharmaceuticals Production Value Market Share by Application (2018-2029)
Figure 52. World 3D Printing Pharmaceuticals Average Price by Application (2018-2029) & (US$/Unit)
Figure 53. 3D Printing Pharmaceuticals Industry Chain
Figure 54. 3D Printing Pharmaceuticals Procurement Model
Figure 55. 3D Printing Pharmaceuticals Sales Model
Figure 56. 3D Printing Pharmaceuticals Sales Channels, Direct Sales, and Distribution
Figure 57. Methodology
Figure 58. Research Process and Data Source
